Aibo Medical Robot
About
About Aibo Medical Robot
Abrobo’s vascular-intervention systems place the physician’s controls apart from the patient-side instrument mechanism. The operator directs catheter and guidewire movement from a console, supporting work away from the immediate X-ray field. The PANVIS-A platform uses fingertip catheter controls and can move instruments independently or synchronise their movement after sheath placement.
The company is developing a family of systems for coronary, neurovascular and broader vascular procedures. For PANVIS-A, it has announced a multicentre real-world study led by Guangdong Provincial People’s Hospital and Zhujiang Hospital of Southern Medical University. This programme evaluates the system in clinical workflows while retaining physician control of the intervention.
Articles
Funding
- 2026-10-15 - A+ - Aibo Medical Robot completes A+ financing for vascular intervention robotics
Aibo Medical Robot, legally Shenzhen Aibo Hechuang Medical Robotics, completed A+ equity financing led by Puhe Capital with strategic participation from Longgang Financial Holding. - source: vbdata.cn
- 2023-06-01 - Series A - $14.1M - Aibo Medical Robot raises RMB 100 million Series A
Aibo Medical Robot raised RMB 100 million in Series A funding to advance vascular-intervention robotics and commercialisation. - source: 36kr.com
Investors
- Changling Capital - Participant - VC - 1 funding event - first seen 2023-06-01
- Guozhong Capital - Participant - VC - 1 funding event - first seen 2023-06-01
- Lenovo Capital - Participant - VC - 1 funding event - first seen 2023-06-01
- Longgang Financial Holding / 龙岗金控 - Participant - Unknown - 1 funding event - first seen 2026-10-15
- Puhe Capital / 普禾资本 - Lead - VC - 1 funding event - first seen 2026-10-15
Timeline
Events
- 2026-10-15 - Funding - Aibo Medical Robot completes A+ financing for vascular intervention robotics
The disclosed amount is tens of millions of renminbi. Proceeds support expanded indications and commercialization of vascular intervention robots, automated and remote-system R&D and registration, and hiring. The PANVIS STAR platform uses five instrument-drive channels for coordinated vascular-intervention tool handling.
Source - 2023-06-01 - Funding - Aibo Medical Robot raises RMB 100 million Series A
Guozhong Capital led the round. Lenovo Capital reinvested and Changling Capital participated. The Shenzhen company was developing robot-assisted vascular intervention systems.
Source